Literature DB >> 9691511

Use of alternative treatment in pediatric oncology.

M A Grootenhuis1, B F Last, J H de Graaf-Nijkerk, M van der Wel.   

Abstract

The use of alternative treatment along with conventional cancer therapy is very popular. However, little is known about the use of alternative treatment in pediatric oncology. A study to determine which medical and demographic characteristics distinguish users from nonusers was conducted in a pediatric oncology sample of children with different survival perspectives. The parents of 84 children with cancer (43 patients in first continuous remission and 41 patients who had suffered a relapse or second malignancy) participated in the study and were surveyed with respect to the use of alternative treatment. The survival perspective appeared to be the most important variable distinguishing users of alternative treatment from nonusers. Twenty-six families (31%) had used or were using alternative treatment, of which 19 were families of children with cancer who had suffered a relapse (46%), and 7 were families of children with cancer in remission (16%). The most common types of alternative treatment used were based on homeopathy and anthroposophy (treatments based on autonomous medical concepts). Because of the finding that lower survival perspective is related to the use of alternative treatment, the use of alternative treatment conceivably could be a coping strategy based on illusions. Therefore, it is recommended that alternative treatment be discussed open-mindedly by all health care providers involved in the care of pediatric oncology patients.

Entities:  

Mesh:

Year:  1998        PMID: 9691511     DOI: 10.1097/00002820-199808000-00010

Source DB:  PubMed          Journal:  Cancer Nurs        ISSN: 0162-220X            Impact factor:   2.592


  21 in total

Review 1.  Complementary and alternative medicine for children: does it work?

Authors:  K J Kemper
Journal:  Arch Dis Child       Date:  2001-01       Impact factor: 3.791

Review 2.  Complementary and alternative medicine for children: does it work?

Authors:  K J Kemper
Journal:  West J Med       Date:  2001-04

3.  [Not Available].

Authors: 
Journal:  Paediatr Child Health       Date:  2005-04       Impact factor: 2.253

4.  Children and natural health products: What a clinician should know.

Authors: 
Journal:  Paediatr Child Health       Date:  2005-04       Impact factor: 2.253

5.  High prevalence of complementary and alternative medicine use in the Dutch pediatric oncology population: a multicenter survey.

Authors:  Maartje Singendonk; Gert-Jan Kaspers; Marianne Naafs-Wilstra; Antoinette Schouten-van Meeteren; Jan Loeffen; Arine Vlieger
Journal:  Eur J Pediatr       Date:  2012-09-19       Impact factor: 3.183

6.  Perceptions about complementary and alternative medicine use among Chinese immigrant parents of children with cancer.

Authors:  Lisa Watt; Sonia Gulati; Nicola T Shaw; Lillian Sung; David Dix; Iraj Poureslami; Anne F Klassen
Journal:  Support Care Cancer       Date:  2011-02-12       Impact factor: 3.603

7.  Use of complementary medicine in pediatric patients with inflammatory bowel disease: results from a multicenter survey.

Authors:  Anthony P Wong; Ann L Clark; Elizabeth A Garnett; Michael Acree; Stanley A Cohen; George D Ferry; Melvin B Heyman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-01       Impact factor: 2.839

8.  Use of homeopathy in pediatric oncology in Germany.

Authors:  Alfred Längler; Claudia Spix; Friedrich Edelhäuser; Genn Kameda; Peter Kaatsch; Georg Seifert
Journal:  Evid Based Complement Alternat Med       Date:  2010-09-22       Impact factor: 2.629

9.  Use of complementary/alternative medicine among paediatric patients.

Authors:  Hanne Madsen; Susie Andersen; Rasmus Gaardskaer Nielsen; Birgitte Sofie Dolmer; Arne Høst; Anette Damkier
Journal:  Eur J Pediatr       Date:  2003-02-27       Impact factor: 3.183

10.  Pediatric acupuncture: a review of clinical research.

Authors:  Jeffrey I Gold; Colette D Nicolaou; Katharine A Belmont; Aaron R Katz; Daniel M Benaron; Wendy Yu
Journal:  Evid Based Complement Alternat Med       Date:  2008-01-10       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.